(Q38720376)

5 September 2017

1 reference

title

The normal and morbid biology of fibrinogen (English)

1 reference

ORCID Public Data File 2021

5 September 2017

1 reference

author name string

Dang CV

series ordinal

1

1 reference

5 September 2017

Bell WR

series ordinal

2

1 reference

5 September 2017

Shuman M

series ordinal

3

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

American Journal of Medicine

5 September 2017

published in

1 reference

5 September 2017

volume

87

1 reference

5 September 2017

issue

5

1 reference

5 September 2017

page(s)

567-576

1 reference

5 September 2017

cites work

Fibrinogen and fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrin: structure and interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

COVALENT STRUCTURE OF FIBRINOGEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

A model for fibrinogen: domains and sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Electron microscope structural study of modified fibrin and a related modified fibrinogen aggregate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

7 January 2021

Fibrinogen heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

.gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Nucleotide sequence of the gene for the gamma chain of human fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Expression of the fibrinogen genes in rat megakaryocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Phosphorylation of human fibrinogen in vitro by calcium-activated phospholipid-dependent protein kinase from pig spleen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Biosynthesis of dog fibrinogen. Characterization of nascent fibrinogen in the rough endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Stimulation of fibrinogen biosynthesis by fibrinogen fragments D and E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Stimulation of fibrinogen synthesis in cultured rat hepatocytes by fibrinogen fragment E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

γ-γ Cross-linking sites in human and bovine fibrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

The platelet-fibrinogen interaction. Evidence for proximity of the A alpha chain of fibrinogen to platelet membrane glycoproteins IIb/III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Calcium-binding regions in fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Carboxylated calcium-binding proteins and vitamin K.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Molecular defects in interactions of platelets with the vessel wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Identification of a region of human fibrinogen interacting with staphylococcal clumping factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Seminars in Thrombosis and Hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen depletion with sodium valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Hypercoagulability and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

The erythrocyte sedimentation rate. Guidelines for rational use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

A naturally occurring antibody that inhibits fibrin polymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Analysis of fibrinogen genes in patients with congenital afibrinogenemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Hereditary hypofibrinogenemia with fibrinogen storage in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

The structure and evolution of vertebrate fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Congenital dysfibrinogenemia: fibrinogen detroit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Seattle releases half the normal amount of fibrinopeptide B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

"Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Baltimore IV: congenital dysfibrinogenemia with delayed fibrin monomer polymerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Factor XIII binds to the A alpha- and B beta- chains in the D-domain of fibrinogen: an immunoblotting study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Regulation of formation of factor XIIIa by its fibrin substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

"Fibrinogen Oklahoma": a study of interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Kinetics and molecular mechanism of the proteolytic fragmentation of fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Biochemistry of human plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Tissue plasminogen activator: chemical and physiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Beta(Leu121-Lys122) segment of fibrinogen is in a region essential for plasminogen binding by fibrin fragment E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

A molecular model of plasmic degradation of crosslinked fibrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

A new type of congenital dysfibrinogenaemia with defective fibrin lysis--Dusard syndrome: possible relation to thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Congenital thrombotic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Acquired dysfibrinogenaemia in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Glycosylation of human fibrinogen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen giessen I: a congenital homozygously expressed dysfibrinogenemia with A alpha 16 Arg----His substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Episodes of increased fibronectin level observed in a patient suffering from recurrent thrombosis related to congenital hypodysfibrinogenaemia (fibrinogen Malmoe).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

Fibrinogen: a possible link between social class and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980616-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(89)80616-3

1 reference

5 September 2017

1 reference